NUVL Collar Strategy
NUVL (Nuvalent, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors, which is under Phase I development; and NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, central nervous system-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under Phase I/II clinical trial. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
NUVL (Nuvalent, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $7.74B, a beta of 1.15 versus the broader market, a 52-week range of 68.64-113.015, average daily share volume of 567K, a public-listing history dating back to 2021, approximately 162 full-time employees. These structural characteristics shape how NUVL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.15 places NUVL roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a collar on NUVL?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current NUVL snapshot
As of May 15, 2026, spot at $102.64, ATM IV 47.30%, IV rank 25.41%, expected move 13.56%. The collar on NUVL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this collar structure on NUVL specifically: IV regime affects collar pricing on both sides; compressed NUVL IV at 47.30% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 13.56% (roughly $13.92 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NUVL expiries trade a higher absolute premium for lower per-day decay. Position sizing on NUVL should anchor to the underlying notional of $102.64 per share and to the trader's directional view on NUVL stock.
NUVL collar setup
The NUVL collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NUVL near $102.64, the first option leg uses a $110.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NUVL chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NUVL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $102.64 | long |
| Sell 1 | Call | $110.00 | $2.93 |
| Buy 1 | Put | $100.00 | $4.90 |
NUVL collar risk and reward
- Net Premium / Debit
- -$10,461.50
- Max Profit (per contract)
- $538.50
- Max Loss (per contract)
- -$461.50
- Breakeven(s)
- $104.62
- Risk / Reward Ratio
- 1.167
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
NUVL collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on NUVL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$461.50 |
| $22.70 | -77.9% | -$461.50 |
| $45.40 | -55.8% | -$461.50 |
| $68.09 | -33.7% | -$461.50 |
| $90.78 | -11.6% | -$461.50 |
| $113.48 | +10.6% | +$538.50 |
| $136.17 | +32.7% | +$538.50 |
| $158.86 | +54.8% | +$538.50 |
| $181.56 | +76.9% | +$538.50 |
| $204.25 | +99.0% | +$538.50 |
When traders use collar on NUVL
Collars on NUVL hedge an existing long NUVL stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
NUVL thesis for this collar
The market-implied 1-standard-deviation range for NUVL extends from approximately $88.72 on the downside to $116.56 on the upside. A NUVL collar hedges an existing long NUVL position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current NUVL IV rank near 25.41% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on NUVL at 47.30%. As a Healthcare name, NUVL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NUVL-specific events.
NUVL collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NUVL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NUVL alongside the broader basket even when NUVL-specific fundamentals are unchanged. Always rebuild the position from current NUVL chain quotes before placing a trade.
Frequently asked questions
- What is a collar on NUVL?
- A collar on NUVL is the collar strategy applied to NUVL (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With NUVL stock trading near $102.64, the strikes shown on this page are snapped to the nearest listed NUVL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are NUVL collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the NUVL collar priced from the end-of-day chain at a 30-day expiry (ATM IV 47.30%), the computed maximum profit is $538.50 per contract and the computed maximum loss is -$461.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a NUVL collar?
- The breakeven for the NUVL collar priced on this page is roughly $104.62 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current NUVL market-implied 1-standard-deviation expected move is approximately 13.56%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on NUVL?
- Collars on NUVL hedge an existing long NUVL stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current NUVL implied volatility affect this collar?
- NUVL ATM IV is at 47.30% with IV rank near 25.41%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.